Applied Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Applied Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q2 2024.
  • Applied Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 115M shares, a 84.9% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 115M +52.7M +84.9% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 114M +66.1M +137% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 84.9M +36.8M +76.6% Dec 31, 2023 10-Q 2024-08-07
Q3 2023 77.1M +29.1M +60.5% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 62.1M +15.9M +34.3% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 48.1M +21.9M +83.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 48.1M +21.8M +83.3% Dec 31, 2022 10-K 2024-03-06
Q3 2022 48.1M +21.8M +83.3% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 46.3M +20.1M +77% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 26.2M +205K +0.79% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 26.2M +3.72M +16.5% Dec 31, 2021 10-K 2023-03-23
Q3 2021 26.2M +3.76M +16.7% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 26.1M +3.8M +17% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 26M +4.04M +18.4% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 22.5M +3.96M +21.4% Dec 31, 2020 10-K 2022-03-10
Q3 2020 22.5M +5.32M +31.1% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 22.3M +5.28M +31% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 22M +16.5M +298% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 18.5M +13M +236% Dec 31, 2019 10-K 2021-03-18
Q3 2019 17.1M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 17.1M Jun 30, 2019 10-Q 2019-08-12
Q1 2019 5.51M Mar 31, 2019 10-Q 2019-06-21
Q4 2018 5.51M Dec 31, 2018 10-K 2020-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.